Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study

J Pijpe, G W van Imhoff, F K L Spijkervet, J L N Roodenburg, G J Wolbink, K Mansour, A Vissink, C G M Kallenberg, H Bootsma

Research output: Contribution to journal › Article › Academic › peer-review

441 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Immunology and Microbiology